Abstract
Based on the initial optimization of orally active antimalarial 2,4-diamino-thienopyrimidines and with the help of metabolite identification studies, a second generation of derivatives involving changes at the 2- and 4-positions of the thienopyrimidine core were synthesized. Improvements in the physiochemical properties resulted in the identification of 15a, 17a, 32, and 40 as lead molecules with improved in vivo exposure. Furthermore, analogue 40 exhibited excellent in vivo antimalarial activity when dosed orally at 50 mg/kg once daily for 4 days in the Plasmodium berghei mouse model, which is superior to the activity seen with previously reported compounds, and with a slightly improved hERG profile.
References
Feb 8, 2002·Nature·Louis H MillerOgobara K Doumbo
Aug 20, 2004·Nature·Jonathan L VennerstromWilliam N Charman
Dec 31, 2004·The Journal of Organic Chemistry·Amy E ThompsonBrian Tarbit
Nov 29, 2005·Molecular Diversity·Natarajan SrinivasanA Ganesan
Jun 23, 2006·Infectious Disorders Drug Targets·Christophe Biot, Kelly Chibale
Aug 18, 2006·Journal of Medicinal Chemistry·Craig JamiesonGrant Wishart
Apr 15, 2008·Drug Discovery Today·Bo LiuTove Tuntland
Oct 17, 2009·Nature Reviews. Drug Discovery·Timothy N C WellsWinston E Gutteridge
Mar 16, 2011·Current Topics in Medicinal Chemistry·Jeremy N BurrowsTimothy N C Wells
Mar 30, 2012·Journal of Medicinal Chemistry·Andrea CavalliMaurizio Recanatini
Sep 18, 2012·Drug Discovery Today·Chun LiTove Tuntland
Jul 19, 2013·Parasitology·Jeremy N BurrowsPaul Willis
Dec 20, 2013·Nature·Frédéric ArieyDidier Ménard
Jan 23, 2014·Journal of Medicinal Chemistry·Diego González CabreraKelly Chibale
Aug 17, 1998·Angewandte Chemie·John F Hartwig
Citations
Jan 18, 2016·European Journal of Medicinal Chemistry·Nalmala DevenderRama Pati Tripathi
Jul 12, 2018·PLoS Neglected Tropical Diseases·Frederick A PartridgeDavid B Sattelle
Jan 8, 2019·ChemMedChem·Clinton G L Veale
Mar 24, 2018·European Journal of Medicinal Chemistry·Alessandra ValloneStefania Butini